Contact lens manufacturer PEGAVISION reported strong revenue for October, reaching NT$702 million—a 12.7% increase month-on-month and 17.6% year-on-year—marking a 23-month high and the third-highest monthly revenue in the company’s history. Cumulative revenue for the first ten months reached NT$5.81 billion, up 3.4% year-on-year, the company’s best performance to date.

Sales of silicone hydrogel products began to scale up, particularly in the European and Japanese markets. Contributions from these regions were already visible in Q3 through orders and revenue, establishing silicone hydrogel as a new growth driver. Revenue is expected to continue growing in Q4, with quarter-on-quarter growth potentially reaching high single-digit percentages. This year, silicone hydrogel products accounted for an estimated 10% of total revenue, with plans to further increase to 15% in 2026.

Entering the traditional peak season in Q4, driven by promotional periods such as Double 11 and Double 12, PEGAVISION’s performance is expected to continue upward. Analysts anticipate the company could achieve high single-digit quarterly growth. For the full year, revenue is expected to increase by single-digit percentages compared to last year. Among markets, Europe and Japan are showing the strongest growth momentum, with projected revenue growth of approximately 15%–20%, while Taiwan remains stable at an estimated 0%–5% growth. In contrast, China’s market has been under continued internal competition, leading to a 15% decline in the first three quarters, with full-year revenue expected to maintain a double-digit decrease.

Resource: 晶碩10月營收雙增衝破七億，創史上第三高